Bayer and Polisan launched the production of contrast media for tomography

27 March 2019

Bayer and Polysan announced the start of commercial production of the original Iopromide contract medium for tomography. The product will be produced on a full cycle at the facilities of the Russian manufacturer in St. Petersburg.

1 700.0 mln
Jobs: 800
Moscow region, St. Petersburg, Sverdlovsk region

Investor profile

Bayer AG

Leverkusen, Germany

Company's website:

T: +49 214 30-1

Public company


Contact: Dr Marijn Dekkers, Chairman of the Board of Directors

Bayer is an international concern specialized in healthcare, agriculture, and high-tech materials.